FdaApplication
NDA 214965
Identifiers
- fda_app_no: NDA214965
Properties
| Property | Value |
|---|---|
| applicant_name | HARROW EYE LLC |
| application_type | NDA |
| approval_date | 2021-06-23 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VERKAZIA | CYCLOSPORINE | 0.1% | EMULSION;OPHTHALMIC |
1 product